Impact of CYP3A5 genotype on tacrolimus management in adult heart transplant recipients

被引：0
|
作者：
Pasternak, Amy [1 ]
Hong, Je-Won [1 ]
Lewis, Sarah [1 ]
机构：
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI USA
来源：
PHARMACOGENETICS AND GENOMICS | 2025年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：35 / 36
页数：2
相关论文
共 50 条
  • [21] Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes
    Can Hu
    Wen-jun Yin
    Dai-yang Li
    Jun-jie Ding
    Ling-yun Zhou
    Jiang-lin Wang
    Rong-rong Ma
    Kun Liu
    Ge Zhou
    Xiao-cong Zuo
    European Journal of Clinical Pharmacology, 2018, 74 : 1437 - 1447
  • [22] Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes
    Hu, Can
    Yin, Wen-jun
    Li, Dai-yang
    Ding, Jun-jie
    Zhou, Ling-yun
    Wan, Jiang-lin
    Ma, Rong-rong
    Liu, Kun
    Zhou, Ge
    Zuo, Xiao-cong
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (11) : 1437 - 1447
  • [23] Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism
    de Jonge, Hylke
    de Loor, Henriette
    Verbeke, Krisitin
    Vanrenterghem, Yves
    Kuypers, Dirk R. J.
    PHARMACOGENOMICS, 2013, 14 (12) : 1467 - 1480
  • [24] ASSOCIATION BETWEEN TACROLIMUS AND CYP3A5 GENOTYPE IN PEDIATRIC KIDNEY TRANSPLANT
    Alghamdi, A.
    Lazear, D.
    Varnell, C.
    Seay, S.
    Hooper, D.
    Darland, L.
    Mizuno, T.
    Ramsey, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S10 - S10
  • [25] AN EFFECT OF DONOR-RECIPIENT CYP3A5 GENOTYPE COMBINATION ON TACROLIMUS EXPOSURE IN RENAL TRANSPLANT RECIPIENTS
    Warzyszynska, Karola
    Karpeta, Edyta
    Kosieradzki, Maciej
    TRANSPLANT INTERNATIONAL, 2021, 34 : 257 - 257
  • [26] The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients
    Prytula, Agnieszka A.
    Cransberg, Karlien
    Bouts, Antonia H. M.
    van Schaik, Ron H. N.
    de Jong, Huib
    de Wildt, Saskia N.
    Mathot, Ron A. A.
    CLINICAL PHARMACOKINETICS, 2016, 55 (09) : 1129 - 1143
  • [27] CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
    Li, Yi
    Yan, Lin
    Shi, Yunying
    Bai, Yangjuan
    Tang, Jiangtao
    Wang, Lanlan
    SPRINGERPLUS, 2015, 4
  • [28] A Systematic Review of the Effect of CYP3A5 Genotype on the Apparent Oral Clearance of Tacrolimus in Renal Transplant Recipients
    Barry, Arden
    Levine, Marc
    THERAPEUTIC DRUG MONITORING, 2010, 32 (06) : 708 - 714
  • [29] COMPARISON OF TACROLIMUS STARTING DOSES BASED ON CYP3A5 PHENOTYPE OR GENOTYPE IN KIDNEY TRANSPLANT RECIPIENTS.
    Largeau, B.
    Noble, J.
    Longuet, H.
    Halimi, J.
    Buchler, M.
    Gatault, P.
    Marquet, P.
    Barin-Le Guellec, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S102 - S103
  • [30] CYP3A5 GENOTYPE IS NOT RELATED TO THE INTRA-PATIENT VARIABILITY OF TACROLIMUS CLEARANCE IN RENAL TRANSPLANT RECIPIENTS
    Spierings, Natalia M. K.
    Pashaee, Nilufar
    Bouamar, Rachida
    Hesselink, Dennis A.
    Roodnat, Joke I.
    van Schaik, Ron H. N.
    Weimar, Willem
    Holt, David W.
    MacPhee, Iain A. M.
    van Gelder, Teun
    TRANSPLANT INTERNATIONAL, 2011, 24 : 80 - 81
12345